Morgan Stanley analyst Cecilia Furlong maintains TransMedics Group (NASDAQ:TMDX) with a Equal-Weight and raises the price target from $34 to $37.
Wego’s Dialysis Business Seeks Hong Kong IPO in MedTech Boom
Key Takeaways:
Weigao Blood Purification filed for a Hong Kong IPO soon after bringing in well-known institutional investors
The company is a domestic leader in China’s blood purification industry across a range of products, including blood filters and dialysis tubing
By Molly Wen